WO2024200719 - COMPOSITION FOR USE
National phase entry:
Publication Number
WO/2024/200719
Publication Date
03.10.2024
International Application No.
PCT/EP2024/058601
International Filing Date
28.03.2024
Title **
[English]
COMPOSITION FOR USE
[French]
COMPOSITION DESTINÉE À UN USAGE PARTICULIER
Applicants **
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Inventors
DOGRA, Shaillay Kumar
SAKWINSKA, Olga
FERRIER, Laurent
Priority Data
23165376.7
30.03.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
* |
| Recordal of a Change of the Applicant's Name/Address | * |
| Type of Assignment | * |
| Applicant's Legal Status | * |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under | * |
| Patent Delivery | * |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2122 | |
| EPO | Filing, Examination, Granting | 8505 | |
| Japan | Filing, Examination, Granting | 2247 | |
| South Korea | Filing, Examination, Granting | 2251 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
21,665
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention provides methods for identifying an infant or young child at risk of stunted growth and compositions for use in preventing and/or treating stunted growth in an infant or young child.[French]
La présente invention concerne des procédés d'identification d'un nourrisson ou d'un enfant en bas âge présentant un risque de retard de croissance et des compositions destinées à être utilisées dans la prévention et/ou le traitement d'un retard de croissance chez un nourrisson ou un enfant en bas âge.